STATE STREET CORP - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 47 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q4 2020$12,047,000
+8.0%
12,157,000
+7.0%
0.00%0.0%
Q3 2020$11,156,000
-13.9%
11,357,000
-14.3%
0.00%0.0%
Q2 2020$12,962,000
+4.8%
13,257,0000.0%0.00%0.0%
Q1 2020$12,365,000
-17.6%
13,257,000
-16.0%
0.00%0.0%
Q4 2019$15,000,000
+6.2%
15,782,000
+1.5%
0.00%0.0%
Q3 2019$14,125,000
-1.7%
15,542,000
-1.0%
0.00%0.0%
Q2 2019$14,374,000
+16.5%
15,692,000
+18.1%
0.00%0.0%
Q1 2019$12,337,000
-4.3%
13,292,000
-7.3%
0.00%0.0%
Q4 2018$12,898,000
-3.0%
14,342,000
+1.2%
0.00%0.0%
Q3 2018$13,295,000
+1.1%
14,172,0000.0%0.00%0.0%
Q2 2018$13,144,000
+8.8%
14,172,000
+3.5%
0.00%0.0%
Q1 2018$12,076,000
+2.9%
13,697,000
+3.0%
0.00%0.0%
Q4 2017$11,734,000
-2.1%
13,297,0000.0%0.00%0.0%
Q3 2017$11,987,000
-35.4%
13,297,000
-23.1%
0.00%
-50.0%
Q2 2017$18,569,000
+11.2%
17,297,000
+10.2%
0.00%
+100.0%
Q1 2017$16,705,000
+5.3%
15,697,000
+8.7%
0.00%0.0%
Q4 2016$15,871,000
-12.3%
14,447,000
+2.6%
0.00%
-50.0%
Q2 2014$18,087,000
+16.1%
14,077,000
+16.6%
0.00%0.0%
Q1 2014$15,584,000
+3.5%
12,077,000
-15.7%
0.00%
+100.0%
Q4 2013$15,056,000
+62.1%
14,327,000
+60.5%
0.00%0.0%
Q3 2013$9,288,0008,927,0000.00%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q2 2017
NameSharesValueWeighting ↓
Southpaw Asset Management LP 20,000,000$17,675,00025.38%
INCOME RESEARCH & MANAGEMENT 23,109,000$20,278,0005.29%
Fore Capital, LLC 5,000,000$4,430,0001.71%
RIVERHEAD CAPITAL MANAGEMENT LLC 20,000,000$17,603,0000.74%
ARISTEIA CAPITAL, L.L.C. 18,500,000$16,361,0000.70%
ZAZOVE ASSOCIATES LLC 11,153,000$9,843,0000.58%
BASSO CAPITAL MANAGEMENT, L.P. 3,600,000$3,182,0000.52%
CSS LLC/IL 10,450,000$9,240,0000.45%
Lombard Odier Asset Management (Europe) Ltd 7,950,000$7,038,0000.44%
Wellesley Asset Management 6,740$5,948,0000.31%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders